These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 28475872)

  • 1. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
    East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
    Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
    Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
    Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
    Swarts DC; van der Oost J; Jinek M
    Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA processing by the CRISPR-associated NYN ribonuclease.
    Chi H; White MF
    Biochem J; 2024 Jun; 481(12):793-804. PubMed ID: 38785320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A scoutRNA Is Required for Some Type V CRISPR-Cas Systems.
    Harrington LB; Ma E; Chen JS; Witte IP; Gertz D; Paez-Espino D; Al-Shayeb B; Kyrpides NC; Burstein D; Banfield JF; Doudna JA
    Mol Cell; 2020 Aug; 79(3):416-424.e5. PubMed ID: 32645367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR RNA and anti-CRISPR protein binding to the
    Hong S; Ka D; Yoon SJ; Suh N; Jeong M; Suh JY; Bae E
    J Biol Chem; 2018 Feb; 293(8):2744-2754. PubMed ID: 29348170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The crystal structure of Cpf1 in complex with CRISPR RNA.
    Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
    Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to study CRISPR RNA biogenesis and the key players involved.
    Behler J; Hess WR
    Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.
    Walker FC; Chou-Zheng L; Dunkle JA; Hatoum-Aslan A
    Nucleic Acids Res; 2017 Feb; 45(4):2112-2123. PubMed ID: 28204542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems.
    Chylinski K; Le Rhun A; Charpentier E
    RNA Biol; 2013 May; 10(5):726-37. PubMed ID: 23563642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus.
    Staals RHJ; Agari Y; Maki-Yonekura S; Zhu Y; Taylor DW; van Duijn E; Barendregt A; Vlot M; Koehorst JJ; Sakamoto K; Masuda A; Dohmae N; Schaap PJ; Doudna JA; Heck AJR; Yonekura K; van der Oost J; Shinkai A
    Mol Cell; 2013 Oct; 52(1):135-145. PubMed ID: 24119403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary processing of CRISPR RNA by the endonuclease Cas6 in Staphylococcus epidermidis.
    Wakefield N; Rajan R; Sontheimer EJ
    FEBS Lett; 2015 Oct; 589(20 Pt B):3197-204. PubMed ID: 26364721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus.
    Karvelis T; Gasiunas G; Miksys A; Barrangou R; Horvath P; Siksnys V
    RNA Biol; 2013 May; 10(5):841-51. PubMed ID: 23535272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
    Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
    Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.